Chromoendoscopy for inflammatory bowel disease

Name: Chromoendoscopy for inflammatory bowel disease
Uploaded: 2017-01-09T00:00:00+00:00
Description: Michael F. Picco, M.D., Ph.D., and Michael B. Wallace, M.D., gastroenterologists at Mayo Clinic's campus in Jacksonville, Florida, demonstrate a simplified technique for application of indicarmine and other staining agents for surveillance in inflammatory bowel disease.

Michael F. Picco, M.D., Ph.D., and Michael B. Wallace, M.D., gastroenterologists at Mayo Clinic's campus in Jacksonville, Florida, demonstrate a simplified technique for application of indicarmine and other staining agents for surveillance in inflammatory bowel disease.

Published

January 9, 2017

Created by

Related Videos

FDA approves biosimilar to Humira — IBD in the news

Edward V. Loftus Jr., M.D., discusses some of the issues surrounding this medication, and its potential benefits and drawbacks.

FDA approves of biosimilar to infliximab — IBD in the news

The FDA recently approved a biosimilar (CT-P13) to infliximab, which is used for treating people with IBD, as well as people with rheumatoid arthritis ankylosing spondylitis, psoriatic arthritis and plaque psoriasis.

Non-celiac gluten sensitivity

Maria I. Vazquez Roque, M.D., discusses non-celiac gluten sensitivity (NCGS).

Mucosal healing in kids with celiac disease — Celiac disease in the news

Imad Absah, M.D., discusses a recently published article in the Journal of Pediatric Gastroenterology and Nutrition about mucosal healing in children with celiac disease.

Radiation therapy associated with a lower risk of recurrence in people with pancreatic cancer

Radiation therapy improves survival times in patients who are candidates for pancreatic cancer surgery.

FISH helps identify biliary tract malignancies

Michael J. Levy, M.D., a consultant in Gastroenterology and Hepatology at Mayo Clinic's campus in Rochester, Minnesota, discusses clinical utility, optimum specimen collection methods.

Mesalamine dose may lower marker of bowel inflammation

Edward V. Loftus Jr., M.D., discusses an article looking at the ability of a drug to drive down calprotectin, a marker of bowel inflammation, in people who have ulcerative colitis.

Grand Rounds — Tales From the Frozen Wasteland: The Epidemiology and Natural History of Crohn's Disease and Ulcerative Colitis in Olmsted County

Edward V. Loftus Jr., M.D., presents Tales From the Frozen Wasteland: The Epidemiology and Natural History of Crohn's Disease and Ulcerative Colitis in Olmsted County.

Fecal microbiota transplantation (FMT)

Mayo Clinic's Robert Orenstein, D.O., and John K. DiBaise, M.D., explain and demonstrate the FMT procedures and techniques.

Medical Professional Video Center

Search Video Center